HIGHLIGHTS
- who: Nadejda Beliakova-Bethell et al. from the Center (SNPRC), United States Washington University in StLouis have published the paper: Monocytic-Myeloid Derived Suppressor Cells Suppress T-Cell Responses in Recovered SARS CoV2-Infected Individuals, in the Journal: (JOURNAL)
- what: The authors investigated CD11b+CD33+CD14+HLADR-/lo monocytic myeloid derived suppressor cells (M-MDSC) in individuals with a history of CoV2 infection (CoV2+) confirmed by RT PCR and individuals without CoV2 (CoV2-). The authors sought to determine if phenotypic T_cell abnormalities persist 5 months from the first detection of CoV2 infection. The authors show . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.